Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Rabies
2021
Americas
Western Pacific
Clear all
Type of publications
NITAG documentation
(72)
Systematic reviews (SYSVAC)
(7)
Topics
Available to download in languages
Regions
Americas
(64)
Western Pacific
(15)
Africa
(17)
Europe
(76)
South-East Asia
(2)
Countries
Argentina
(1)
Australia
(11)
Bolivia
(2)
Canada
(16)
Chile
(9)
China
(4)
United States of America
(36)
Diseases
COVID-19
(78)
Rabies
(1)
Ebola
(1)
Herpes zoster
(1)
Human papillomavirus (HPV)
(5)
Influenza
(4)
Meningococcal disease
(1)
Pertussis
(2)
Pneumococcal disease
(2)
Rotavirus
(2)
Varicella
(1)
Vaccine topics
Acceptance
(1)
Coverage
(1)
Ethical issues
(2)
Safety
(1)
Target population
Adults
(4)
All age groups
(5)
Children
(3)
Healthcare workers
(1)
Older adults
(3)
Parents/caregivers
(1)
Pregnant women
(4)
Publication date
2021
(79)
2024
(1)
2023
(15)
2022
(57)
2020
(81)
2018
(1)
2010
(1)
2009
(1)
2008
(1)
79 results found
2021
∙
ACIP
ACIP Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12–15 Years - May 12, 2021
2021
∙
ACIP
ACIP Updated Recommendations for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients - 27 April 2021
2021
∙
Sara Oliver, ACIP
ACIP Work Group interpretations of data
2021
∙
ATAGI
Advice on the relative timing of administering influenza and COVID-19 vaccines in 2021
2021
∙
ACIP
AstraZeneca COVID-19 vaccine (AZD1222)
2021
∙
ATAGI
ATAGI advice on seasonal influenza vaccines in 2021 - 8 June 2021
2021
∙
ATAGI
ATAGI clinical guidance on COVID-19 vaccine in Australia - 13 April, 2021
2021
∙
ATAGI
ATAGI Guidance on Myocarditis and Pericarditis after mRNA COVID-19 vaccines - 9 August 2021
2021
∙
ATAGI
ATAGI immunisation provider guide to obtaining informed consent for COVID-19 vaccine.
2021
∙
ATAGI
ATAGI statement on SARS-CoV-2 Omicron variant and COVID-19 booster doses
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register